NIH-funded research NIH-funded research

New ways to stop tooth decay in young children

Official title: A multiscale approach to develop and apply fluoride efflux inhibitors to reverse oral dysbiosis and eliminate early childhood caries

Funded at University of Michigan at Ann Arbor · NIH-11192320 · Data updated 2026-11-12

This project looks for new ways to stop tooth decay in young children by targeting specific germs in the mouth that cause cavities.

More Dysbiosis research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startSeptember 12, 2024
Project endJune 30, 2029
Funding year2025
Award (this year)$1,071,751
NIH project number5RM1DE034220-02
Project IDNIH-11192320 on NIH RePORTER

Who could benefit from this research

Could help

This research is focused on understanding and treating early childhood caries, which affects children aged 0-11 years old.

Less likely to help

Patients without early childhood caries or those outside the pediatric age range may not directly benefit from this specific research.

What this research studies

Early childhood tooth decay is a major problem for many children, causing pain and affecting their health. This project aims to find new treatments that can specifically target the harmful bacteria and fungi that cause cavities, while leaving helpful germs alone. Researchers are developing special compounds called fluoride efflux inhibitors that can make fluoride more effective against these cavity-causing microbes. By understanding how these germs get rid of fluoride, we hope to create a more balanced and healthy mouth environment for children.

Why it matters

Potential benefit: If successful, this work could lead to new and more effective ways to prevent and treat early childhood tooth decay, reducing pain and improving children's overall health.

How similar studies have gone: Fluoride is a known effective agent for caries control, but this approach of specifically targeting microbial fluoride expulsion mechanisms is novel and largely untested.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Stockbridge, Randy B. — University of Michigan at Ann Arbor
  • Study coordinator: Stockbridge, Randy B.

Related research

Other NIH-funded projects on the same topics.

  • Microbial Dysbiosis and Its Role in Pancreatic Cancer

    A doctor-researcher team at Northwestern University is studying how gut bacteria influence pancreatic cancer and its response to immunotherapy to find new ways to help patients.

    NIH research Northwestern University · Chicago, United States · NIH-11624054

  • From Symbiosis to Dysbiosis: How Resolving Inflammation Could Restore Your Mouth’s Balance

    This grant explores how turning off the harmful inflammation in periodontitis and promoting natural healing could help restore the mouth’s healthy balance.

    NIH research Ada Forsyth Institute, INC. · Somerville, UNITED STATES · NIH-11621747

  • Antibiotics, gut health, and skin reactions in kids

    A small study in children will look at whether antibiotic use and gut bacteria play a role in hives and related symptoms that children sometimes get after antibiotics.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11603169

  • Novel therapeutic to protect the gut after radiation

    A new GI-directed treatment given after radiation exposure may reduce gut damage and improve survival in people exposed to high-dose radiation.

    NIH research Columbia University Health Sciences · New York, United States · NIH-11572662

  • A new GI-focused treatment to reduce radiation damage after exposure

    A potential GI-targeted therapy given after radiation exposure may help protect the gut and improve survival in people affected by radiation injuries.

    NIH research Columbia University Health Sciences · New York, United States · NIH-11572658

  • How a mouth bacterium might fuel gum disease and heart risk

    A small study will look at how a bacterium in the mouth that makes a reactive chemical (methylglyoxal) could drive gum inflammation and changes in the mouth’s bacteria, possibly linking to heart disease.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11564245

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.